Trademark: 90420060
Word
SANGAMO THERAPEUTICS
Status
Pending
Status Code
734
Status Date
Friday, August 9, 2024
Serial Number
90420060
Mark Type
4
Filing Date
Monday, December 28, 2020
Published for Opposition
Tuesday, December 28, 2021

Trademark Owner History
Sangamo Therapeutics, Inc. - Owner At Publication

Classifications
5 Biochemicals, biologics, and pharmaceutical preparations, namely, reagents in the nature of engineered proteins for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for clinical medical use and medical use in the fields of human and animal therapeutics, diagnostics, bioinformatics, genetic diseases, gene therapy, and cell therapy; Reagents, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for clinical medical use and medical use
45 Licensing of intellectual property rights
1 Biochemicals and biologics, namely, engineered proteins in raw material form for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for use in scientific research, medical pharmaceutical research, scientific agricultural biotechnology research, medical diagnostics research, industrial scientific biotechnology research and all for clinical medical laboratory use and medical laboratory use in the fields of human and animal therapeutics, diagnostics, bioinformatics, genetic diseases, gene therapy, and cell therapy; engineered proteins in raw material form for use in scientific research and analysis relating to genetic diseases, gene therapy, cell therapy, genome editing, and genome regulation; biochemicals and biologics, namely, reagents in the nature of engineered nucleic acids for laboratory use, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins in raw material form for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for use in scientific research, analysis and diagnostics and all for medical clinical laboratory use and medical laboratory use
42 Medical and scientific research; technical scientific research and medical research consulting in the fields of bioinformatics and gene regulation, gene modification, and gene correction; product research and development of engineered proteins and nucleic acids for others; product design of genetic research tools and systems for others; custom product development of engineered proteins for use in gene editing
"THERAPEUTICS"

Trademark Events
Dec 31, 2020
New Application Entered
Jun 30, 2021
Notification Of Non-Final Action E-Mailed
Mar 17, 2021
New Application Office Supplied Data Entered
Jun 24, 2021
Assigned To Examiner
Jun 30, 2021
Non-Final Action Written
Jun 30, 2021
Non-Final Action E-Mailed
Nov 15, 2021
Teas Response To Office Action Received
Nov 15, 2021
Correspondence Received In Law Office
Nov 15, 2021
Teas/Email Correspondence Entered
Nov 23, 2021
Approved For Pub - Principal Register
Dec 8, 2021
Notification Of Notice Of Publication E-Mailed
Dec 28, 2021
Published For Opposition
Dec 28, 2021
Official Gazette Publication Confirmation E-Mailed
Feb 22, 2022
Noa E-Mailed - Sou Required From Applicant
Aug 22, 2022
Fax Received
Aug 22, 2022
Sou Extension 1 Filed
Aug 23, 2022
Itu Office Action Issued For Extension Request
Sep 19, 2022
Response To Itu Office Action Entered
Sep 19, 2022
Teas Response To Office Action Received
Sep 26, 2022
Sou Extension 1 Granted
Sep 27, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 20, 2023
Sou Teas Extension Received
Feb 15, 2023
Teas Change Of Owner Address Received
Feb 15, 2023
Teas Change Of Correspondence Received
Feb 15, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 18, 2023
Sou Extension 3 Granted
Feb 20, 2023
Sou Extension 2 Filed
Feb 20, 2023
Sou Extension 2 Granted
Feb 22, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 18, 2023
Sou Teas Extension Received
Aug 18, 2023
Sou Extension 3 Filed
Feb 22, 2024
Sou Teas Extension Received
Aug 22, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 22, 2024
Sou Extension 4 Filed
Feb 22, 2024
Sou Extension 4 Granted
Feb 23, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 9, 2024
Sou Teas Extension Received
Aug 9, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 9, 2024
Sou Extension 5 Granted
Aug 9, 2024
Sou Extension 5 Filed

Trademark Alertz updated from USPTO on 2030-01-24